Jointown Pharmaceutical Group Co., Ltd. (600998)
Market Closed
10 Aug, 06:57
SSE SSE Primary ¥
5. 05
+0.06
+1.2024%
¥
24.91B Market Cap
- P/E Ratio
1% Div Yield
45.45M Volume
- Eps
¥ 4.99
Previous Close Want to track 600998 and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Summary
600998 closed today higher at ¥5.05, an increase of 1.2024% from yesterday's close, completing a monthly increase of 7.6759% or ¥0.36. Over the past 12 months, 600998 stock lost -1.5595%.
600998 pays dividends to its shareholders, with the most recent payment made on Jun 08, 2026. The next estimated payment will be in In 9 months on Jun 08, 2027 for a total of ¥0.2.
The last earnings report, released on Apr 28, 2026, missed the consensus estimates by -0.1346%. On average, the company has fell short of earnings expectations by -0.0615%, based on the last three reports.
Jointown Pharmaceutical Group Co., Ltd. has completed 3 stock splits, with the recent split occurring on Jun 07, 2024.
The company's stock is traded on one exchange.
600998 Chart
People also search for
Jointown Pharmaceutical Group Co., Ltd. (600998) FAQ
What is the stock price today?
The current price is ¥5.05.
On which exchange is it traded?
Jointown Pharmaceutical Group Co., Ltd. is listed on SSE.
What is its stock symbol?
The ticker symbol is 600998.
Does it pay dividends? What is the current yield?
Yes, It pays dividends and the current yield is 1%.
What is its market cap?
As of today, the market cap is 24.91B.
Has Jointown Pharmaceutical Group Co., Ltd. ever had a stock split?
Jointown Pharmaceutical Group Co., Ltd. had 3 splits and the recent split was on Jun 07, 2024.
Jointown Pharmaceutical Group Co., Ltd. Profile
| Consumer Staples Distribution & Retail Industry | Consumer Staples Sector | Mr. Wei He CEO | SSE Exchange | CNE100000W45 ISIN |
| CN Country | 30,100 Employees | 8 Jun 2026 Last Dividend | 7 Jun 2024 Last Split | 2 Nov 2010 IPO Date |
Overview
Jointown Pharmaceutical Group Co., Ltd is a leading entity in China's pharmaceutical sector, offering comprehensive supply chain services. Founded in 1999 and headquartered in Wuhan, China, the company has significantly expanded its footprint across the pharmaceutical industry. It not only emphasizes on the distribution of pharmaceutical products but also engages in a wide array of activities including general agency brand promotion, digital retail solutions, intelligent logistics, and supply chain management tailored for the healthcare sector. Furthermore, Jointown is dedicated to exploring the integration of medical health services with advanced technology to provide value-added services, thereby enhancing the overall healthcare ecosystem in China.
Products and Services
- Pharmaceutical Supply Chain Services - Central to its core business, Jointown specializes in streamlining the distribution and delivery of pharmaceutical products across China, employing innovative logistics and supply chain solutions to ensure efficiency and reliability.
- General Agency Brand Promotion - The company serves as a crucial intermediary, helping pharmaceutical brands to establish and expand their presence in the competitive Chinese market through effective promotion and marketing strategies.
- Digital Retail - Embracing the digital transformation, Jointown offers modern retail solutions that leverage technology to enhance the accessibility and convenience of purchasing pharmaceutical products for consumers.
- Intelligent Logistics and Supply Chain Solutions - Jointown employs state-of-the-art technology to optimize logistics and supply chain operations, improving the cost-effectiveness and speed of pharmaceutical deliveries.
- Medical Health and Technology Value-Added Services - The company is at the forefront of integrating medical services with technology, developing innovative solutions that contribute to the advancement of healthcare services and patient care.
- Manufacturing of Western Medicines
- Antibiotics - Jointown produces a range of antibiotic medications aimed at treating various bacterial infections, addressing a critical need in healthcare.
- Anti-Diabetic Drugs - The company manufactures medications for the management and treatment of diabetes, a prevalent chronic disease affecting millions worldwide.
- Cardiovascular Drugs - Focusing on heart health, Jointown offers a spectrum of pharmaceuticals designed to treat cardiovascular conditions, contributing to the prevention of heart diseases.
- OEM Medicines - Beyond its proprietary products, Jointown also engages in the manufacturing of OEM (Original Equipment Manufacturer) medicines, catering to the diverse needs of clients requiring customized pharmaceutical solutions.
Contact Information
Address: No. 8, Longyang Avenue, Wuhan, China, 430051
Phone: 86 40 0160 0998
Website: https://www.jztey.com
